Inovio Pharmaceuticals
INO
INO
101 hedge funds and large institutions have $54.6M invested in Inovio Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
2.68% less ownership
Funds ownership: 48.07% → 45.4% (-2.7%)
17% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 23
Holders
101
Holding in Top 10
–
Calls
$1.12M
Puts
$469K
Top Buyers
| 1 | +$1.7M | |
| 2 | +$471K | |
| 3 | +$208K | |
| 4 |
Renaissance Technologies
New York
|
+$149K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$130K |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$835K | |
| 3 | -$388K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$321K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$319K |
